Navigation Links
Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits
Date:11/11/2010

THOUSAND OAKS, Calif., Nov. 11, 2010 /PRNewswire/ -- Amgen today announced the 11 recipients of the Amgen Excellence in Volunteering Awards. Launched this year by the Amgen Foundation, the Awards recognize staff in the United States (U.S.) and Puerto Rico who are making a difference in the communities where the company has a presence. The Amgen Foundation will award $5,000 to each nonprofit organization featured in the winning staff members' applications.

"At Amgen, we are committed to strengthening our communities through grantmaking, matching staff contributions and volunteering," said Jean J. Lim, president of the Amgen Foundation. "Many of our staff have made a true impact in the community through volunteer efforts and we aim to grow this support by recognizing outstanding volunteers through the annual Amgen Excellence in Volunteering Awards program."

The recipients were selected by a panel of external reviewers from key community groups based on impact of the applicant's volunteer efforts, frequency of volunteer activity and length of time committed, and a letter of recommendation from the nonprofit organization.

2010 Amgen Excellence in Volunteering Awards Recipients

California

  • Ogo Egbuna, Research and Development, volunteer for Conejo Free Clinic
  • Kim Larkins, Research and Development, volunteer for Habitat for Humanity of Ventura County
  • Chris Lindsay, Sales and Marketing, volunteer for the Girl Scouts of California's Central Coast
  • Bella Oguno, Research and Development, volunteer for International Medical Relief
  • Chris Wright, Worldwide Business Continuity & Crisis Management, volunteer for National Disaster Search Dog Foundation

Colorado

  • Ralph Payne, Manufacturing, volunteer for Livermore Fire Protection District

Field Staff

  • Susan McHugh, Sales and Marketing, volunteer for Tammany Trace Foundation in Louisiana

Massachusetts

  • Matthew Weiss, Research and Development, volunteer for Big Brothers Big Sisters of Massachusetts Bay

Puerto Rico

  • Ana Delma Lebron, Manufacturing, volunteer for Puerto Rico Youth at Risk

Rhode Island

  • Richard Fitzpatrick, Security and Emergency Services, volunteer for Neutaconkanut Hill Conservancy

Washington

  • Justine Dell'Aringa, Research and Development, volunteer for Seattle Tilth Association

Click here to view complete details about the recipients.

As a part of the Amgen Volunteers program, the Amgen Excellence in Volunteering Awards will annually recognize outstanding staff volunteers from Amgen's U.S. and Puerto Rico sites and field-based staff and will provide a $5,000 award to each nonprofit organization featured in the winning staff members' applications. To be considered, Amgen staff were asked to complete an application with information about their volunteer services and provide a letter of recommendation from the nonprofit organization.

Amgen Volunteers is an Amgen Foundation program that connects staff members with local volunteer opportunities they are passionate about, and provides $500 Volunteer Service Grants to eligible nonprofit organizations for every 15 hours volunteered by Amgen staff. Since 2007, more than $1.5 million has been contributed as a result of staff volunteer efforts in their local communities.

The Amgen Foundation also matches staff contributions to eligible nonprofit organizations. Since 1993, the Amgen Foundation has matched $23 million in staff donations, resulting in nearly $47 million of support to worthy causes. In 2009 alone, Amgen Foundation matched more than 8,800 staff member gifts resulting in nearly $6.5 million to support the work of outstanding organizations.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

About the Amgen Foundation

The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally.

CONTACT:  Amgen, Thousand Oaks

Kristen Davis, (805) 447-3008 (media)

(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Amgen to Provide Testimony at FDA Hearing on Biosimilars
2. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
3. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
4. Array BioPharma and Amgen Partner in Type 2 Diabetes
5. Amgen to Present at Lazard Capital Healthcare Conference
6. Amgen Announces Webcast of 2009 Third Quarter Financial Results
7. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
8. Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
9. Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
10. Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
11. Amgen Exercises Option for Exclusive License to Cytokinetics Cardiac Contractility Program That Includes CK-1827452
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 Australian-US drug discovery ... announced today the appointment of a new Chairman, Mr ... Carmine , effective immediately. James Garner , ... Executive Director and former Acting CEO, Mr Iain Ross ... Non-Executive Director. --> James Garner , has also ...
(Date:2/4/2016)... ... 04, 2016 , ... Shimadzu Scientific Instruments will showcase several ... and poster sessions, and present on the analysis of mycotoxins and medical cannabis ... to 10 at the Georgia World Congress Center in Atlanta, Georgia. , ...
(Date:2/4/2016)... and MENLO PARK, Calif. , Feb. ... ("DelMar" and the "Company"), a biopharmaceutical company focused on the ... it will present at the 18 th Annual ... 2016 at 10:00 a.m. EST in New York, ... president and CEO, will provide an update on the ongoing ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... China , today announced that the ... February 4, 2016 a preliminary non-binding proposal letter, dated ... V-Ming ( Shanghai ) Investment Holdings Co., ... Shenzhen ) Fund Management Co., Ltd., Beijing ...
Breaking Biology Technology:
(Date:1/20/2016)... SAN JOSE, Calif. , Jan. 20, 2016 ... leading developer of human interface solutions, today announced ... touch controller solution for wearables and small screen ... appliances such as printers. Supporting round and rectangular ... the S1423 offers excellent performance with moisture on ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
(Date:1/7/2016)... -- Various factors have contributed to the rise ... and biosimilars. Some of these factors include the ... for cost-effective alternatives, growing burden of chronic diseases, ... of their corresponding patented biologic drugs, and are ... efficacy. The global biosimilars market is estimated to ...
Breaking Biology News(10 mins):